Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$122.13

-0.33 (-0.27%)

, AMD

AMD

$23.95

0.27 (1.14%)

08:55
02/20/19
02/20
08:55
02/20/19
08:55

Notable open interest changes for February 20th

Tuesday's total option volume of 16.3 million contracts resulted in net open interest growth of 3.47 million calls and 3.45 million puts. Eli Lilly (LLY), AMD (AMD), Apple (AAPL) and General Electric (GE) saw the greatest growth. Top five new positions opened include 48k Eli Lilly (LLY) Mar-19 150 calls, 48k Eli Lilly (LLY) Mar-19 150 puts, 24k Elanco Animal Health (ELAN) Mar-19 40 puts, 23k Elanco Animal Health (ELAN) Mar-19 40 calls and 21k Target (TGT) Apr-19 80 calls.

LLY

Eli Lilly

$122.13

-0.33 (-0.27%)

AMD

AMD

$23.95

0.27 (1.14%)

AAPL

Apple

$170.95

0.61 (0.36%)

GE

General Electric

$10.13

0.045 (0.45%)

  • 27

    Feb

  • 18

    May

LLY Eli Lilly
$122.13

-0.33 (-0.27%)

01/18/19
WBLR
01/18/19
DOWNGRADE
WBLR
Market Perform
Loxo Oncology downgraded to Market Perform from Outperform at William Blair
William Blair analyst Raju Prasad downgraded Loxo Oncology (LOXO) to Market Perform citing the likelihood of the takeover by Eli Lilly (LLY) closing at the agreed upon price.
01/18/19
JPMS
01/18/19
NO CHANGE
JPMS
Overweight
Eli Lilly trial miss a 'moderate setback,' says JPMorgan
JPMorgan analyst Chris Schott calls Eli Lilly's Phase 3 trial miss of Lartruvo in combination with doxorubicin in patients with advanced or metastatic soft tissue sarcoma a "moderate" setback.
01/23/19
UBSW
01/23/19
INITIATION
Target $131
UBSW
Buy
Eli Lilly initiated with a Buy at UBS
UBS analyst Navin Jacob started Eli Lilly with a Buy rating and $131 price target. The analyst's analysis suggests the company's diabetes franchise growth, Verzenio adjuvant trial success and operating margin expansion are not fully appreciated in the stock or estimates
01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
AMD AMD
$23.95

0.27 (1.14%)

02/15/19
RSBL
02/15/19
NO CHANGE
Target $190
RSBL
Buy
Nvidia price target raised to $190 from $170 at Rosenblatt
Rosenblatt analyst Hans Mosesmann raised his price target for Nvidia (NVDA) to $190 and reiterates a Buy rating on the shares following the company's Q4 results. The "crypto mess" is finally bottoming in the April quarter and management sees a "material snap-back" starting in fiscal Q2 and the rest of the year, Mosesmann tells investors in a post-earnings research note titled "Crypto Bottoming - Aggressive Snapback - Stock Works for LT Investors." However, amid Datacenter and Gaming industry uncertainty, the analyst believes management is "needlessly being aggressive" with its outlook. He points out that, though, that both Intel (INTC) and AMD (AMD) are also being aggressive for their own year guides. Mosesmann remains a long-term bull on the Nvidia story and believes new traction in inferencing and enterprise market segments will sustain high growth rates in Datacenter for years to come.
02/13/19
RBCM
02/13/19
NO CHANGE
RBCM
RBC Capital sees Google data centers news as positive for AMD, Nvidia
RBC Capital analyst Mitch Steves sees news of Google (GOOG; GOOGL) planning to spend about $13B to build new data centers in Nevada, Ohio, Texas and Nebraska along with additional expansion plans for the Virginia and NY City campuses as an incremental positive for AMD (AMD), Nvidia (NVDA), Arista Networks (ANET) and the Semi-cap equipment group, including Lam Research (LRCX), ASML (ASML), and Applied Materials (AMAT). One of the material concerns over the past few months has been hyperscale spending and this announcement should help quell fears surrounding a weaker spending environment, he contends.
02/05/19
FBCO
02/05/19
NO CHANGE
FBCO
Neutral
Credit Suisse trims AMD earnings estimates after Mubadala transaction
Credit Suisse analyst John Pitzer trimmed his 2019 earnings per share estimate for AMD to 59c from 60c and 2020 estimate to 78c from 80c to reflect a higher share count after Mubadala sold 34.9M shares and announced its intent to exercise 75M warrants at $5.98 into common equity shares. Importantly, around 55M of the 75M shares from the warrants were already embedded in AMD's Q1 and 2019 diluted shares outstanding guidance, Pitzer tells investors in a research note. As such, he does not view today's transaction as meaningful either to AMD's financial model or underlying investment narrative. However, the analyst continues to view AMD's 2019 guidance as "optically aggressive" since it implies the fastest quarter-over-quarter growth in the company's history. Pitzer keeps a Neutral rating on AMD. The stock in afternoon trading is down 4%, or 99c, to $23.14.
02/05/19
STFL
02/05/19
NO CHANGE
Target $34
STFL
Buy
Any AMD weakness on Mubadala transactions a buying opportunity, says Stifel
Stifel analyst Kevin Cassidy noted that Mubadala Investment Company announced that they sold a block of 34.9M AMD shares, which represents about 3.5% of the outstanding shares on a fully diluted basis, and also announced their intent to exercise 75M AMD warrants into common equity shares. As a result, Mubadala will own about 6.9% of outstanding AMD shares, said Cassidy, who views the announcement as normal investment transactions for the group. He recommends investors use any AMD share weakness to build a long position and keeps a Buy rating and $34 price target on the stock.
AAPL Apple
$170.95

0.61 (0.36%)

02/07/19
MSCO
02/07/19
NO CHANGE
Target $99
MSCO
Overweight
PayPal acceptance growth still best of any digital wallet, says Morgan Stanley
Morgan Stanley analyst James Faucette said the most common question he has gotten for the past several weeks on PayPal (PYPL) has been, "Why is the stock underperforming so much since the beginning of 2019?" He believes PayPal's recent plateauing probably has more to do with other stocks than anything stock-specific, stating that Visa (V) and MasterCard (MA) "really have arguably had their best buying opportunities in years" and he would not be surprised to see PayPal "tread water" until those two stocks retake their respective highs. Another common thread in talks has been increasing concern that other digital wallets from Amazon (AMZN), Apple (AAPL) and others may be closing the acceptance gap, though he thinks that "speculation is flatly wrong." Dating back to March 2016, PayPal has had the fastest acceptance growth among all digital wallets, outpacing all the other wallets that he can reliably track, Faucette tells investors. He maintains an Overweight rating and $99 price target on PayPal shares.
02/15/19
JEFF
02/15/19
NO CHANGE
Target $160
JEFF
Hold
Apple Services growth unlikely to offset iPhone declines, says Jefferies
It appears that Apple will likely announce its new over-the-top streaming service as soon as late March for a potential Spring release, Jefferies analyst Timothy O'Shea tells investors in a research note titled "Apple Video Coming Soon; Not Feeling the Love." The analyst says that while Apple Video represents upside to his detailed Services model, unfavorable economics might discourage third party content producers from participating, limiting its growth potential. He thinks the service will operate similarly to the App Store where Apple will take a 30% revenue cut. Further, O'Shea points out that it would take 250M subscribers to represent 5% of 2023 revenue. For now Services growth is unlikely to offset iPhone unit declines, which should persist through 2019, contends the analyst. He keeps a Hold rating on Apple with a $160 price target. The iPhone maker closed yesterday unchanged at $170.80.
02/20/19
JPMS
02/20/19
NO CHANGE
Target $228
JPMS
Overweight
JPMorgan's iPhone supplier tracker shows early signs of stabilization
JPMorgan analyst Samik Chatterjee says that while his firm's iPhone Supplier Tracker decelerated seasonally in January, the latest trends could be indicative of stabilization. Aggregate revenues for the suppliers in the tracker declined by 24% month-over-month in January, which compares to a 22% decline the suppliers have seen historically going from the month of December to January, Chatterjee tells investors in a research note. Additionally, on a year-over-year basis, aggregate revenue rose by 2% in January, in what we believe could be early signs of a stabilization, says the analyst. He keeps an Overweight rating on Apple with a $228 price target.
02/20/19
LOOP
02/20/19
NO CHANGE
Target $160
LOOP
Hold
Loop Capital lowers estimates on Apple's 2019 iPhone revenue, unit sales
Loop Capital analyst Ananda Baruah kept his Hold rating and $160 price target on Apple, saying his deeper analysis of the iPhone capacity mix implies lower expected 2019 device revenue of $130B - down from $147B prior forecast - and reduced unit sales estimate of 180M vs. 191M prior. The analyst notes that channel costs, discounting, and supply issue factors cloud visibility, but warns that "pronounced seasonality for the March quarter, ongoing softness in China's economy, and an elongating upgrade cycle" could also alter the dynamics of the current quarter.
GE General Electric
$10.13

0.045 (0.45%)

02/01/19
WBLR
02/01/19
NO CHANGE
WBLR
Outperform
GE shares hitting $14-$16 'highly feasible' in 6-12 months, says William Blair
William Blair analyst Nicholas Heymann ascribes General Electric's 12% share price rise yesterday following its Q4 results to an "inflection in investor sentiment, not short-covering." He believes this occurred in mid-December after the stock bottomed at $6.66. GE ended 2018 "strongly" with "notably better-than-feared" free cash flow, year-over-year organic Industrial growth of 8% for sales and 4% for orders in Q4, and "slightly positive" net price in 2018 that sequentially improved in the second half, Heymann tells investors in a post-earnings research note titled "Up, Up, and Away: New CEO Accelerating Turnaround Pace; Free Cash Flow Better than Feared; Largest Litigation Resolved." The analyst also believes the turnaround of GE Power "is in the very early innings with the process, timing, and 2019 performance yet to be fully detailed." Despite the lack of 2019 detailed guidance, there is no fundamental case for GE shares to have further downside risk, says Heymann. The company's liquidity is "ample," its original targeted proceeds from asset sales are now being expanded and completed earlier than expected, and unknown risks and litigation are being resolved in line with prior reserves, the analyst contends. He keeps an Outperform rating on General Electric. Heymann continues to believe GE's underlying intrinsic value, assigning no value to Power, is somewhere in the range of $14- $16 per share. The analyst sees this range as a "highly feasible base case valuation" for GE's share price over the next 6-12 months. GE closed yesterday at $10.16 per share.
02/01/19
RBCM
02/01/19
NO CHANGE
Target $12
RBCM
Outperform
General Electric price target raised to $12 from $10 at RBC Capital
RBC Capital analyst Deane Dray raised his price target on General Electric to $12 and kept his Outperform rating, saying the angst about its "liquidity shortfall or fire sale" on its best assets has been "quelled" by its Q4 results. The analyst notes that CEO Larry Culp has acknowledged that the turnaround map for the company is "not yet complete", but he sees the "lack of negatives" in the quarter as a positive. Dray also points to General Electric's seasonally strong free cash flows, adding that its next catalyst should be the upcoming analyst meeting.
02/01/19
UBSW
02/01/19
NO CHANGE
Target $12
UBSW
Buy
General Electric turnaround in early stages, says UBS
UBS analyst Peter Lennox-King noted that General Electric's Q4 results were weak, but said that was of less importance than other key issues. He believes the company is in the early stages of a turnaround and that renewables is positioned well on revenue into the PTC expiration. Lennox-King reiterated his Buy rating and $12 price target on General Electric shares.
02/01/19
JPMS
02/01/19
NO CHANGE
Target $6
JPMS
Neutral
JPMorgan's Tusa views GE stock rally as head scratcher, keeps $6 price target
In a post-earnings research note titled "The Math Still Matters," JPMorgan analyst Stephen Tusa says he came away from the General Electric's Q4 scratching his head at the stock reaction. Shares of GE closed yesterday up 12%, or $1.06, to $10.16. The analyst attributes the rally to the company's "incrementally better" free cash flow, the "nominal nature" of the Q4 insurance charge, and credibility of the CEO. However, Tusa views the key aspect as more clarity on de-leveraging around where the "value" of the assets is going, and then the "ongoing lack of visibility on the simple math that shows a negative run rate" on enterprise free cash flow fully diluted for portfolio moves. Even assuming recovery in Power, "one has to make highly optimistic assumptions to get back to a run rate that supports anything near $10" per share, Tusa writes. In vowing to "stick to the numbers," Tusa says his read through from GE's Q4 results reaffirms his "well below-consensus model." Overall, "there was a lack of tangible details on key items," Tusa contends. He keeps a Neutral rating on General Electric with a $6 price target.

TODAY'S FREE FLY STORIES

SDXAY

Sodexo

$0.00

(0.00%)

09:03
09/23/19
09/23
09:03
09/23/19
09:03
Hot Stocks
Sodexo confirms 34% carbon emissions reduction target by 2025 »

Sodexo confirmed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Conference/Events
UBS to hold a conference »

Future of Retail…

AJG

Arthur J. Gallagher

$88.78

-0.64 (-0.72%)

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Hot Stocks
Arthur J. Gallagher acquires The Human Capital Group, terms not disclosed »

Arthur J. Gallagher &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$172.68

-4.23 (-2.39%)

09:01
09/23/19
09/23
09:01
09/23/19
09:01
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

, CHWY

Chewy

$26.44

-1.06 (-3.85%)

08:59
09/23/19
09/23
08:59
09/23/19
08:59
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: Plus Therapeutics…

MNK

Mallinckrodt

$2.46

0.01 (0.41%)

CHWY

Chewy

$26.44

-1.06 (-3.85%)

ALV

Autoliv

$78.20

-1.06 (-1.34%)

PSTV

Plus Therapeutics

$7.96

-0.34 (-4.10%)

TELL

Tellurian

$8.69

0.105 (1.22%)

RKDA

Arcadia Biosciences

$5.29

-0.23 (-4.17%)

CLF

Cleveland-Cliffs

$7.73

-0.235 (-2.95%)

X

U.S. Steel

$10.81

-0.25 (-2.26%)

AKS

AK Steel

$2.41

-0.05 (-2.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 02

    Oct

  • 31

    Oct

ABMD

Abiomed

$193.14

0.48 (0.25%)

08:59
09/23/19
09/23
08:59
09/23/19
08:59
Hot Stocks
Federal Court of Justice in Germany rules in favor of Abiomed's Impella patents »

The highest court in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

MU

Micron

$49.17

-0.65 (-1.30%)

08:58
09/23/19
09/23
08:58
09/23/19
08:58
Recommendations
Micron analyst commentary  »

Deutsche comfortable with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CRUS

Cirrus Logic

$54.36

-0.59 (-1.07%)

, NXPI

NXP Semiconductors

$104.69

-3.74 (-3.45%)

08:55
09/23/19
09/23
08:55
09/23/19
08:55
Recommendations
Cirrus Logic, NXP Semiconductors, Texas Instruments analyst commentary  »

Teardown confirms Cirrus…

CRUS

Cirrus Logic

$54.36

-0.59 (-1.07%)

NXPI

NXP Semiconductors

$104.69

-3.74 (-3.45%)

TXN

Texas Instruments

$126.70

-2.1 (-1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

NFLX

Netflix

$270.66

-15.92 (-5.56%)

, ROKU

Roku

$107.98

-25.735 (-19.25%)

08:55
09/23/19
09/23
08:55
09/23/19
08:55
Options
Notable open interest changes for September 23rd »

Friday's total…

NFLX

Netflix

$270.66

-15.92 (-5.56%)

ROKU

Roku

$107.98

-25.735 (-19.25%)

BAC

Bank of America

$29.57

-0.23 (-0.77%)

AAPL

Apple

$217.69

-3.22 (-1.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 16

    Oct

  • 16

    Oct

SABR

Sabre

$23.11

0.12 (0.52%)

08:54
09/23/19
09/23
08:54
09/23/19
08:54
Hot Stocks
Sabre signs long-term agreement with Magnum Travel Services »

Sabre announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DG

Dollar General

$156.29

-0.66 (-0.42%)

08:53
09/23/19
09/23
08:53
09/23/19
08:53
Recommendations
Dollar General analyst commentary  »

Dollar General price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 30

    Sep

CLF

Cleveland-Cliffs

$7.73

-0.235 (-2.95%)

08:51
09/23/19
09/23
08:51
09/23/19
08:51
Downgrade
Cleveland-Cliffs rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

INPX

Inpixon

$0.13

0.0013 (0.98%)

08:50
09/23/19
09/23
08:50
09/23/19
08:50
Hot Stocks
Inpixon's Jibestream signs teaming agreement with IDENTOS »

Jibestream announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
09/23/19
09/23
08:50
09/23/19
08:50
General news
NY Fed's repo results: Fed's repo totaled $65.75 B »

NY Fed's repo…

CGNX

Cognex

$48.20

-2.28 (-4.52%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Recommendations
Cognex analyst commentary  »

Cognex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AA

Alcoa

$21.70

-0.26 (-1.18%)

, X

U.S. Steel

$10.81

-0.25 (-2.26%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Downgrade
Alcoa, U.S. Steel, Commercial Metals, Nucor, Steel Dynamics, Stelco Holdings rating change  »

JPMorgan double…

AA

Alcoa

$21.70

-0.26 (-1.18%)

X

U.S. Steel

$10.81

-0.25 (-2.26%)

CMC

Commercial Metals

$17.94

-0.42 (-2.29%)

NUE

Nucor

$52.62

-0.08 (-0.15%)

STLD

Steel Dynamics

$30.38

-0.32 (-1.04%)

STZHF

Stelco Holdings

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 16

    Oct

ABEO

Abeona Therapeutics

$3.26

-0.005 (-0.15%)

08:48
09/23/19
09/23
08:48
09/23/19
08:48
Hot Stocks
Abeona recieves clinical hold letter from FDA over Phase 3 trial for EB-101 »

Abeona Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FNB

F.N.B.

$11.38

-0.045 (-0.39%)

08:47
09/23/19
09/23
08:47
09/23/19
08:47
Hot Stocks
F.N.B. announces $150M stock repurchase program »

F.N.B. announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

08:47
09/23/19
09/23
08:47
09/23/19
08:47
Hot Stocks
Resverlogix to present BETonMACE trial results at AHA Scientific Sessions »

Resverlogix announced the…

PRSP

Perspecta

$26.29

-0.005 (-0.02%)

08:46
09/23/19
09/23
08:46
09/23/19
08:46
Hot Stocks
Perspecta awarded $657M extension of NGEN contract with U.S. Dept. of Navy »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

08:45
09/23/19
09/23
08:45
09/23/19
08:45
Hot Stocks
Apple partners with Oprah Winfrey to bring Oprah's Book Club to Apple »

Apple and Oprah Winfrey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BYND

Beyond Meat

$155.23

0.19 (0.12%)

, HEXO

HEXO Corp

$4.37

0.425 (10.79%)

08:45
09/23/19
09/23
08:45
09/23/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BYND

Beyond Meat

$155.23

0.19 (0.12%)

HEXO

HEXO Corp

$4.37

0.425 (10.79%)

FCAU

Fiat Chrysler

$13.52

-0.11 (-0.81%)

ABBV

AbbVie

$72.46

0.78 (1.09%)

QSR

Restaurant Brands

$72.64

-1.24 (-1.68%)

COTY

Coty

$10.17

-0.1 (-0.97%)

ADI

Analog Devices

$115.30

-0.72 (-0.62%)

NOK

Nokia

$5.30

0.145 (2.81%)

IMMU

Immunomedics

$16.60

-0.44 (-2.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 12

    Nov

08:45
09/23/19
09/23
08:45
09/23/19
08:45
General news
U.S. Chicago National Activity index rose 0.51 points to 0.10 in August »

U.S. Chicago National…

NTGR

Netgear

$30.67

0.64 (2.13%)

08:44
09/23/19
09/23
08:44
09/23/19
08:44
Hot Stocks
Netgear joins Open Security and Safety Alliance »

NETGEAR announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$18.85

(0.00%)

08:42
09/23/19
09/23
08:42
09/23/19
08:42
Recommendations
L Brands analyst commentary  »

Jefferies reiterates call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 21

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.